+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast to 2030- Product Image
Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast to 2030- Product Image
Sale

Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904903
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunoassay Market grew from USD 28.29 billion in 2024 to USD 30.38 billion in 2025. It is expected to continue growing at a CAGR of 7.18%, reaching USD 42.90 billion by 2030.

Introduction to Next-Generation Immunoassay Dynamics

The immunoassay sector stands at the forefront of diagnostic innovation, driving critical advancements in healthcare, biotechnology, and pharmaceutical research. As analytical techniques become more sensitive and specific, immunoassays have expanded their role from traditional laboratory settings into point-of-care applications, heralding a new era of rapid, accurate testing. This executive summary distills the pivotal developments, regulatory shifts, and market forces shaping the landscape, providing leaders with a concise yet comprehensive overview. By examining technological breakthroughs, evolving end-user demands, and emerging applications across therapeutic areas, this introduction lays the groundwork for strategic decision-making and future investment in immunoassay platforms.

Accelerating Breakthroughs Redefining Immunoassay Innovation

In recent years, the immunoassay landscape has undergone a transformative shift driven by the convergence of miniaturization, digital integration, and advanced biochemistry. Microfluidic devices have enabled assays on chip-scale platforms, reducing sample volumes and accelerating time to result. Concurrently, the integration of biosensors with software and services has introduced real-time data analytics, unlocking new levels of operational efficiency and predictive diagnostics. These technological leaps are complemented by the growth of lateral flow assays and fluorescent immunoassays, which have scaled to meet point-of-care demands. As laboratories and healthcare providers increasingly prioritize throughput, accuracy, and user experience, the industry’s trajectory reflects an era of rapid iteration and cross-disciplinary collaboration.

United States Tariffs 2025 Reshaping Market Access

The implementation of new United States tariffs in 2025 has introduced significant cost pressures across imported raw materials, reagents, and instrumentation. Suppliers of antibodies, antigens, blocking reagents, enzymes, buffers, and substrates have recalibrated pricing models to accommodate increased duties, resulting in a ripple effect throughout procurement and budget planning. Beyond reagents, the duties on analyzers, microplates, and PCR devices have compelled instrument manufacturers to explore alternative supply chains and domestic partnerships. As a consequence, some end users have shifted toward regionally manufactured microfluidic devices and software services to mitigate cost escalations. Despite these challenges, the tariffs have spurred localized research collaborations and strategic manufacturing alignments aimed at preserving both affordability and quality.

Deep Dive into Immunoassay Market Segmentation

A nuanced understanding of market segmentation is essential for stakeholders to align product development, marketing, and distribution strategies. When considering type differentiation, qualitative immunoassays remain integral for initial screening applications, while quantitative immunoassays drive decision-making in clinical and research settings where precise biomarker levels are critical. Technological segmentation underscores enzyme immunoassays and enzyme-linked immunosorbent assays as well-established platforms, whereas rapid-growth segments such as fluorescent immunoassays and lateral flow assays cater to decentralized testing. Radioimmunoassays and Western blot continue to serve niche research and confirmatory roles. Instrumentation-wise, analysts rely on high-throughput analyzers and microplates for large-scale studies, whereas emerging adoption of biosensors and microfluidic devices supports on-the-spot diagnostics. PCR devices complement immunoassays by validating pathogen-specific nucleic acids in infectious disease workflows, while software and services streamline data management across complex assay pipelines. The reagents category, dissected into antibodies, antigens, blocking reagents, buffers and standards, enzymes, and substrates, forms the biochemical backbone of assay performance. Blood, saliva, tissue, and urine sample types each present unique preparation challenges and regulatory considerations, making tailored solutions imperative. Detection modes range from chemiluminescent and colorimetric methods favored for sensitivity and simplicity to fluorometric assays designed for multiplexed analyses, and the less common radioisotopic techniques used in specialized research. Across application areas, allergy and autoimmune disease diagnostics coexist alongside cardiology, endocrinology, infectious disease, oncology, and toxicology, the latter subdivided into drug screening and environmental testing. Finally, end users span contract research organizations, diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, as well as research institutions, each demanding specific performance characteristics and support structures. Adoption scenarios vary between laboratory tests in centralized settings and point-of-care tests for rapid field deployments.

Regional Market Nuances Driving Immunoassay Adoption

Geographic dynamics play a critical role in shaping immunoassay adoption and investment. In the Americas, robust healthcare infrastructure and extensive funding for infectious disease and oncology research continue to drive high-volume procurement of instruments and reagents. As laboratories seek to upgrade from colorimetric to chemiluminescent detection modes, suppliers are tailoring offerings to meet regional regulatory requirements and reimbursement frameworks. In Europe, the Middle East & Africa region, diverse economic maturity levels create a dual market where established Western European countries demand advanced automation and cloud-connected software solutions, while emerging markets prioritize cost-effective lateral flow assays and decentralized testing capabilities. Compliance with stringent regulatory regimes in Europe coexists with efforts to expand diagnostic access in the Middle East and Africa through partnerships and mobile testing units. The Asia-Pacific region stands out for its rapid expansion in pharmaceutical and biotechnology R&D, fueled by government initiatives and private investment. Local production of microplates, reagents, and analyzers is on the rise to address supply chain resilience, while innovative fluorescent immunoassay platforms emerge from leading academic centers. Increasing disease burden and growing awareness of personalized medicine propel demand for quantitative immunoassays, particularly in cardiology, endocrinology, and oncology applications.

Competitive Horizon in the Immunoassay Arena

The competitive landscape is marked by established multinational corporations and agile specialized firms vying for leadership. Key players leverage comprehensive portfolios that integrate analyzers, kits, and software services to deliver end-to-end solutions. Strategic alliances between reagent suppliers and instrument manufacturers streamline product offerings, while standalone biosensor developers focus on niche applications such as point-of-care infectious disease diagnostics. Leading diagnostic companies invest heavily in R&D to expand into chemiluminescent and fluorometric detection modes, and they often secure partnerships with research institutions to validate platform performance. Emerging entrants differentiate themselves through microfluidic device innovations, compact analyzers designed for low-resource settings, and proprietary software algorithms that enhance data interpretation. Across the spectrum, companies emphasize regulatory compliance, quality certifications, and global distribution networks to meet the evolving needs of contract research organizations, diagnostic laboratories, hospitals, clinics, and pharmaceutical companies.

Strategic Imperatives for Industry Stakeholders

Industry leaders must adopt a multifaceted approach to capitalize on market opportunities and mitigate risks. First, investing in scalable digital platforms that integrate assay data with laboratory information systems can enhance operational transparency, reduce turnaround times, and support compliance. Second, diversifying supply chains through regional manufacturing partnerships decreases vulnerability to tariff fluctuations and logistical disruptions. Third, accelerating development of multiplexed fluorometric immunoassays enables simultaneous detection of multiple biomarkers, catering to the growing demand for personalized diagnostics. Fourth, establishing collaborative frameworks with research institutions in high-growth regions fosters innovation and facilitates faster market entry. Lastly, implementing tiered product portfolios that balance premium and value offerings ensures coverage across laboratory test and point-of-care segments, maximizing market share while maintaining margins.

Rigorous Framework Guiding the Analysis Process

Our research methodology combines rigorous secondary and primary data collection to ensure comprehensive coverage of the immunoassay market. Secondary sources include peer-reviewed journals, regulatory filings, conference proceedings, and public company disclosures, providing a robust foundation of technological, clinical, and market intelligence. Primary research encompasses structured interviews with C-suite executives, laboratory directors, procurement managers, and key opinion leaders across regions, capturing real-world insights into purchasing criteria, unmet needs, and emerging trends. Data validation is achieved through triangulation, cross-referencing supplier reports, and synthesizing quantitative and qualitative inputs. The analytical framework integrates SWOT and PESTEL analyses to assess internal capabilities, external influences, and regulatory dynamics. All findings undergo peer review by subject matter experts to uphold accuracy and objectivity, ensuring that the resulting recommendations are both actionable and strategically aligned.

Synthesizing Insights for a Resilient Market Outlook

As the immunoassay market continues to evolve, stakeholders equipped with comprehensive, nuanced intelligence will be best positioned to navigate competitive pressures and regulatory shifts. Technological innovations, from microfluidics to multiplexed detection modes, will redefine performance benchmarks and expand application horizons. Meanwhile, tariff-induced supply chain realignments underscore the importance of regional manufacturing and strategic alliances. By leveraging detailed segmentation insights and regional nuances, industry players can tailor product portfolios to meet diverse end-user requirements and regulatory landscapes. Ultimately, a proactive stance grounded in data-driven recommendations will enable organizations to seize growth opportunities, drive sustainable innovation, and maintain leadership in an increasingly dynamic market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Qualitative Immunoassays
    • Quantitative Immunoassays
  • Technology
    • Enzyme Immunoassays
    • Enzyme-Linked Immunosorbent Assay
    • Fluorescent Immunoassay
    • Lateral Flow Assay
    • Radioimmunoassay
    • Western Blot
  • Instruments
    • Analyzers & Kits
    • Biosensors
    • Microfluidic Devices
    • Microplates
    • PCR Devices
    • Reagents
      • Antibodies
      • Antigens
      • Blocking Reagents
      • Buffers & Standards
      • Enzymes
      • Substrates
    • Software & Services
  • Sample Types
    • Blood Samples
    • Saliva Samples
    • Tissue Samples
    • Urine Samples
  • Detection Modes
    • Chemiluminescent
    • Colorimetric
    • Fluorometric
    • Radioisotopic
  • Application Areas
    • Allergy
    • Autoimmune Diseases
    • Cardiology
    • Endocrinology
    • Infectious Diseases
    • Oncology
    • Toxicology
      • Drug Screening
      • Environmental Testing
  • End Users
    • Contract Research Organizations
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
    • Research Institutions
  • Deployment Types
    • Laboratory Tests
    • Point-of-care Test
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Almac Group Limited
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Diasorin S.p.A.
  • Dynex Technologies, Inc.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Koninklijke Philips N.V.
  • Merck KGaA
  • MiCo BioMed, Inc.
  • NanoEntek
  • Nanōmix, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc. (Formarly PerkinElmer, Inc.)
  • Sekisui Diagnostics, LLC
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising chronic and infectious diseases and benefits of early diagnosis
5.1.1.2. Emerging application of multiplex detection immunoassay technique in drug development
5.1.1.3. Increasing need for point-of-care immunoassay testing kits
5.1.2. Restraints
5.1.2.1. Concerns associated with product recall for immunoassay instruments
5.1.3. Opportunities
5.1.3.1. Increasing government support and funding fosters research and development in immunoassay technologies
5.1.3.2. Technological advancements in the automated equipment associated with immunoassay
5.1.4. Challenges
5.1.4.1. Issues with assay validation due to variations in sample quality and reagent performance
5.2. Market Segmentation Analysis
5.2.1. Deployment Type: Significant preference for point of care point of care in immunoassay
5.2.2. Application Areas: Adoption of immunoassay in allergy diagnostics to obtain comprehensive results quickly
5.2.3. Technology: Utilization of ELISA for detecting proteins, peptides, and hormones in biological samples
5.2.4. Instruments: Wide utility of analyzer to ensure high throughput and accuracy
5.2.5. Sample Types: Increasing the use of saliva samples in immunoassay for rapid and at-home testing
5.2.6. Detection Modes: Rising usage of fluorometric detection due to its enhanced sensitivity and multiplexing capabilities
5.2.7. End Users: Usage of assays in hospitals & clinics to provide swift and reliable results for diagnostics and patient monitoring
5.2.8. Type: Growing emphasis on personalized medicine and advancements in oncology drives the adoption of quantitative immunoassays
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Immunoassay Market, by Type
6.1. Introduction
6.2. Qualitative Immunoassays
6.3. Quantitative Immunoassays
7. Immunoassay Market, by Technology
7.1. Introduction
7.2. Enzyme Immunoassays
7.3. Enzyme-Linked Immunosorbent Assay
7.4. Fluorescent Immunoassay
7.5. Lateral Flow Assay
7.6. Radioimmunoassay
7.7. Western Blot
8. Immunoassay Market, by Instruments
8.1. Introduction
8.2. Analyzers & Kits
8.3. Biosensors
8.4. Microfluidic Devices
8.5. Microplates
8.6. PCR Devices
8.7. Reagents
8.7.1. Antibodies
8.7.2. Antigens
8.7.3. Blocking Reagents
8.7.4. Buffers & Standards
8.7.5. Enzymes
8.7.6. Substrates
8.8. Software & Services
9. Immunoassay Market, by Sample Types
9.1. Introduction
9.2. Blood Samples
9.3. Saliva Samples
9.4. Tissue Samples
9.5. Urine Samples
10. Immunoassay Market, by Detection Modes
10.1. Introduction
10.2. Chemiluminescent
10.3. Colorimetric
10.4. Fluorometric
10.5. Radioisotopic
11. Immunoassay Market, by Application Areas
11.1. Introduction
11.2. Allergy
11.3. Autoimmune Diseases
11.4. Cardiology
11.5. Endocrinology
11.6. Infectious Diseases
11.7. Oncology
11.8. Toxicology
11.8.1. Drug Screening
11.8.2. Environmental Testing
12. Immunoassay Market, by End Users
12.1. Introduction
12.2. Contract Research Organizations
12.3. Diagnostic Laboratories
12.4. Hospitals & Clinics
12.5. Pharmaceutical & Biotechnology Companies
12.6. Research Institutions
13. Immunoassay Market, by Deployment Types
13.1. Introduction
13.2. Laboratory Tests
13.3. Point-of-care Test
14. Americas Immunoassay Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Immunoassay Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Immunoassay Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2023
17.2. FPNV Positioning Matrix, 2023
17.3. Competitive Scenario Analysis
17.3.1. ADx and Alamar Biosciences Partner to enhance neurodegenerative disease biomarker detection
17.3.2. Emery pharma and Marin Biologic partnership to streamline drug development
17.3.3. VION Biosciences expands diagnostic capabilities with strategic acquisition of Ansh Labs
17.3.4. Bio-Rad's launch of SPIA plus transforms specialty immunoassay testing with precision controls
17.3.5. Roche acquires LumiraDx's Point of Care technology platform for sustainable healthcare improvements
17.3.6. Beckman Coulter advances healthcare with new chemistry and immunoassay analyzer
17.3.7. MilliporeSigma and Merck KGaA partneres to enhance research through SMCxPRO immunoassay technology
17.3.8. Beckman Coulter and MeMed strengthen partnership to enhance infection diagnostics
17.3.9. Fujirebio and Agappe partnership for local manufacturing of CLIA based immunoassays
17.3.10. Fujirebio and Sysmex to collaborate on development of unique immunoassays
17.3.11. Shimadzu Corporation invested in IMMUNOSENS Co., Ltd. for implementation of immunoassay technology
17.3.12. Fapon rolls out new chemiluminescence immunoassay system
17.3.13. Beckman Coulter's DxI 9000 immunoassay analyzer with increased assay development sensitivity
17.3.14. Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer’s Disease Test
17.3.15. SGS offers enhanced automated immunoassay testing at Poitiers Laboratory
17.4. Strategy Analysis & Recommendation
17.4.1. Danaher Corporation
17.4.2. F. Hoffmann-La Roche Ltd.
17.4.3. Siemens Healthineers AG
17.4.4. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. IMMUNOASSAY MARKET MULTI-CURRENCY
FIGURE 2. IMMUNOASSAY MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNOASSAY MARKET RESEARCH PROCESS
FIGURE 4. IMMUNOASSAY MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2023 VS 2030 (%)
FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2023 VS 2030 (%)
FIGURE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2023 VS 2030 (%)
FIGURE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2023 VS 2030 (%)
FIGURE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 27. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 29. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 32. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 33. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOASSAY MARKET DYNAMICS
TABLE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUALITATIVE IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUANTITATIVE IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZERS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY PCR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOCKING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY BUFFERS & STANDARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOASSAY MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOASSAY MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOISOTOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOASSAY MARKET SIZE, BY ALLERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IMMUNOASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL IMMUNOASSAY MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL IMMUNOASSAY MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOASSAY MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 93. CANADA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CANADA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 96. CANADA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 97. CANADA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 98. CANADA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 99. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 100. CANADA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 101. CANADA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 102. CANADA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 103. MEXICO IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 145. CHINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. CHINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. CHINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 149. CHINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 150. CHINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 151. CHINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 152. CHINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 153. CHINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 154. CHINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 155. INDIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. INDIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. INDIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 159. INDIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 160. INDIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 161. INDIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 162. INDIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 163. INDIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 164. INDIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 175. JAPAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. JAPAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. JAPAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 179. JAPAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 180. JAPAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 181. JAPAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 182. JAPAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 183. JAPAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 184. JAPAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 235. THAILAND IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. THAILAND IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 238. THAILAND IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 239. THAILAND IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 240. THAILAND IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 241. THAILAND IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 243. THAILAND IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 244. THAILAND IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 245. VIETNAM IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. VIETNAM IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 248. VIETNAM IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 266. DENMARK IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. DENMARK IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. DENMARK IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 270. DENMARK IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 271. DENMARK IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 272. DENMARK IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 274. DENMARK IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 275. DENMARK IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 276. EGYPT IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. EGYPT IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. EGYPT IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 280. EGYPT IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 281. EGYPT IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 282. EGYPT IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 283. EGYPT IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 284. EGYPT IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 285. EGYPT IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 286. FINLAND IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. FINLAND IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 291. FINLAND IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 292. FINLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 293. FINLAND IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 294. FINLAND IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 295. FINLAND IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 296. FRANCE IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 297. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. FRANCE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 299. FRANCE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 300. FRANCE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 301. FRANCE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 302. FRANCE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 303. FRANCE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 304. FRANCE IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 305. FRANCE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 306. GERMANY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 307. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. GERMANY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 309. GERMANY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 310. GERMANY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 311. GERMANY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 312. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 313. GERMANY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 314. GERMANY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 315. GERMANY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 326. ITALY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 327. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. ITALY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 329. ITALY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 330. ITALY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 331. ITALY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 332. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 333. ITALY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 334. ITALY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 335. ITALY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 346. NIGERIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 347. NIGERIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 348. NIGERIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 349. NIGERIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 350. NIGERIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 351. NIGERIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 352. NIGERIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 353. NIGERIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 354. NIGERIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 355. NIGERIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 356. NORWAY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. NORWAY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 358. NORWAY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 359. NORWAY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 360. NORWAY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 361. NORWAY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 362. NORWAY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 363. NORWAY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 364. NORWAY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 365. NORWAY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 366. POLAND IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 367. POLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 368. POLAND IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 369. POLAND IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 370. POLAND IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2030 (USD MILLION)
TABLE 371. POLAND IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2030 (USD MILLION)
TABLE 372. POLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 373. POLAND IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2030 (USD MILLION)
TABLE 374. POLAND IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 375. POLAND IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2030 (USD MILLION)
TABLE 376. QATAR IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 377. QATAR IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 378. QATAR IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 379. QATAR IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 380. QATAR IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2

Companies Mentioned

The companies profiled in this Immunoassay market report include:
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Almac Group Limited
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Diasorin S.p.A.
  • Dynex Technologies, Inc.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Koninklijke Philips N.V.
  • Merck KGaA
  • MiCo BioMed, Inc.
  • NanoEntek
  • Nanōmix, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc. (Formarly PerkinElmer, Inc.)
  • Sekisui Diagnostics, LLC
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 30.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 42.9 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned47

Related Topics

Related Reports

Single-Molecule Immunoassay Instrument Market by Application, Technology, Product Type, End User, Labeling Technique - Global Forecast to 2030 - Product Image

Single-Molecule Immunoassay Instrument Market by Application, Technology, Product Type, End User, Labeling Technique - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Automated Immunoassay Analyzers Market by Product Type, End User, Throughput, Technology, Application - Global Forecast to 2030 - Product Image

Automated Immunoassay Analyzers Market by Product Type, End User, Throughput, Technology, Application - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 190 Pages
  • Global
From
Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.